BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7626627)

  • 1. Identification of apolipoprotein B100 polymorphisms that affect low-density lipoprotein metabolism: description of a new approach involving monoclonal antibodies and dynamic light scattering.
    Chatterton JE; Schlapfer P; Bütler E; Gutierrez MM; Puppione DL; Pullinger CR; Kane JP; Curtiss LK; Schumaker VN
    Biochemistry; 1995 Jul; 34(29):9571-80. PubMed ID: 7626627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of allele-specific, receptor-binding-defective low density lipoproteins from familial defective apolipoprotein B-100 subjects.
    Arnold KS; Balestra ME; Krauss RM; Curtiss LK; Young SG; Innerarity TL
    J Lipid Res; 1994 Aug; 35(8):1469-76. PubMed ID: 7989871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying low-density lipoprotein-monoclonal antibody complexes using dynamic laser light scattering and analytical ultracentrifugation.
    Gutierrez MM; Tsai SW; Phillips ML; Curtiss LK; Milne RW; Schumaker VN
    Biochemistry; 1999 Jan; 38(4):1284-92. PubMed ID: 9930989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach.
    Pietzsch J; Wiedemann B; Julius U; Nitzsche S; Gehrisch S; Bergmann S; Leonhardt W; Jaross W; Hanefeld M
    J Lipid Res; 1996 Oct; 37(10):2074-87. PubMed ID: 8906585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.
    Myant NB; Gallagher JJ; Knight BL; McCarthy SN; Frostegård J; Nilsson J; Hamsten A; Talmud P; Humphries SE
    Arterioscler Thromb; 1991; 11(3):691-703. PubMed ID: 1674216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The apolipoprotein B R3531C mutation. Characteristics of 24 subjects from 9 kindreds.
    Pullinger CR; Gaffney D; Gutierrez MM; Malloy MJ; Schumaker VN; Packard CJ; Kane JP
    J Lipid Res; 1999 Feb; 40(2):318-27. PubMed ID: 9925662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of an asparagine to lysine mutation at amino acid 3516 of apolipoprotein B on low-density lipoprotein receptor binding.
    Gaffney D; Pullinger CR; O'Reilly DS; Hoffs MS; Cameron I; Vass JK; Kulkarni MV; Kane JP; Schumaker VN; Watts GF; Packard CJ
    Clin Chim Acta; 2002 Jul; 321(1-2):113-21. PubMed ID: 12031600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500-->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins.
    Durovic S; März W; Frank S; Scharnagl H; Baumstark MW; Zechner R; Kostner GM
    J Biol Chem; 1994 Dec; 269(48):30320-5. PubMed ID: 7982944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity.
    Pullinger CR; Hennessy LK; Chatterton JE; Liu W; Love JA; Mendel CM; Frost PH; Malloy MJ; Schumaker VN; Kane JP
    J Clin Invest; 1995 Mar; 95(3):1225-34. PubMed ID: 7883971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein B.
    Young SG; Bertics SJ; Curtiss LK; Casal DC; Witztum JL
    Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1101-5. PubMed ID: 2419898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heritable allele-specific differences in amounts of apoB and low-density lipoproteins in plasma.
    Gavish D; Brinton EA; Breslow JL
    Science; 1989 Apr; 244(4900):72-6. PubMed ID: 2565046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular mechanism for the genetic disorder familial defective apolipoprotein B100.
    Borén J; Ekström U; Agren B; Nilsson-Ehle P; Innerarity TL
    J Biol Chem; 2001 Mar; 276(12):9214-8. PubMed ID: 11115503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The apoB-100 gene EcoRI polymorphism influences the relationship between features of the insulin resistance syndrome and the hyper-apoB and dense LDL phenotype in men.
    Vohl MC; Tchernof A; Dionne FT; Moorjani S; Prud'homme D; Bouchard C; Nadeau A; Lupien PJ; Després JP
    Diabetes; 1996 Oct; 45(10):1405-11. PubMed ID: 8826978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ApaLI restriction site polymorphism is associated with the MB19 polymorphism in apolipoprotein B.
    Young SG; Hubl ST
    J Lipid Res; 1989 Mar; 30(3):443-9. PubMed ID: 2470848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation of apolipoprotein B-100 in circulating LDL is related to LDL residence time. In vivo insights from stable-isotope studies.
    Pietzsch J; Lattke P; Julius U
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E63-7. PubMed ID: 11031225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins.
    Ludwig EH; Hopkins PN; Allen A; Wu LL; Williams RR; Anderson JL; Ward RH; Lalouel JM; Innerarity TL
    J Lipid Res; 1997 Jul; 38(7):1361-73. PubMed ID: 9254062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans.
    Goldberg IJ; Wagner WD; Pang L; Paka L; Curtiss LK; DeLozier JA; Shelness GS; Young CS; Pillarisetti S
    J Biol Chem; 1998 Dec; 273(52):35355-61. PubMed ID: 9857078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric assessment of LDL ligand function for detection of heterozygous familial defective apolipoprotein B-100.
    Raungaard B; Heath F; Hansen PS; Brorholt-Petersen JU; Jensen HK; Faergeman O
    Clin Chem; 2000 Feb; 46(2):224-33. PubMed ID: 10657378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of defective binding of low density lipoprotein by the U937 proliferation assay in German patients with familial defective apolipoprotein B-100.
    Schewe CK; Schuster H; Hailer S; Wolfram G; Keller C; Zöllner N
    Eur J Clin Invest; 1994 Jan; 24(1):36-41. PubMed ID: 8187806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins.
    Weisgraber KH; Innerarity TL; Newhouse YM; Young SG; Arnold KS; Krauss RM; Vega GL; Grundy SM; Mahley RW
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9758-62. PubMed ID: 3200853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.